Prevalence of asthma in Portuguese adults - the EPI-ASTHMA study, a nationwide population-based surveyUnidade Local Saude Viseu Dao Lafoes, Alves Martins Family Hlth Unit, Viseu, Portugal..
Univ Porto, Ctr Hlth Technol & Serv Res CINTESIS, Fac Med, Porto, Portugal..
Univ Porto, Ctr Hlth Technol & Serv Res CINTESIS, Fac Med, Porto, Portugal..
Univ Porto, Ctr Hlth Technol & Serv Res CINTESIS, Fac Med, Porto, Portugal..
MEDIDA Lda, Porto, Portugal..
Assoc P5 Digital Med Ctr ACMP5, Braga, Portugal..
Unidade Local Saude Braga, Vida Family Hlth Unit, Braga, Portugal..
Astrazeneca, Lisbon, Portugal..
Univ Minho, ICVS 3Bs, PT Govt Associate Lab, Life & Hlth Sci Res Inst ICVS,Sch Med, Braga, Portugal.;Assoc P5 Digital Med Ctr ACMP5, Braga, Portugal..
Univ Porto, CINTESIS RISE, MEDCIDS, Fac Med, Porto, Portugal.;Univ Porto, Fac Med, Dept Community Med Informat & Hlth Decis Sci MEDCI, Porto, Portugal..
Unidade Local Saude St Antonio, Bom Porto Family Hlth Unit, Porto, Portugal.;Univ Porto, Inst Publ Hlth, EPI Unit, Porto, Portugal..
Univ Porto, Fac Med, Dept Community Med Informat & Hlth Decis Sci MEDCI, Porto, Portugal.;Univ Porto, Ctr Hlth Technol & Serv Res CINTESIS, Fac Med, Porto, Portugal.;CUF Porto Hosp & Inst, Allergy Unit, Porto, Portugal..
Astrazeneca, Lisbon, Portugal..
Unidade Local Saude Baixo Mondego, Araceti Family Hlth Unit, Coimbra, Portugal..
Assoc P5 Digital Med Ctr ACMP5, Braga, Portugal..
Univ Porto, Inst Publ Hlth, EPI Unit, Porto, Portugal.;Lab Integrat & Translat Res Populat Hlth ITR, Porto, Portugal..
Assoc P5 Digital Med Ctr ACMP5, Braga, Portugal..
Univ Porto, CINTESIS RISE, MEDCIDS, Fac Med, Porto, Portugal.;Univ Porto, Fac Med, Dept Community Med Informat & Hlth Decis Sci MEDCI, Porto, Portugal..
Astrazeneca, Lisbon, Portugal..
Assoc P5 Digital Med Ctr ACMP5, Braga, Portugal..
Assoc P5 Digital Med Ctr ACMP5, Braga, Portugal..
Astrazeneca, Lisbon, Portugal..
Univ Minho, ICVS 3Bs, PT Govt Associate Lab, Life & Hlth Sci Res Inst ICVS,Sch Med, Braga, Portugal..
Univ Porto, CINTESIS RISE, MEDCIDS, Fac Med, Porto, Portugal.;Univ Porto, Fac Med, Dept Community Med Informat & Hlth Decis Sci MEDCI, Porto, Portugal.;MEDIDA Lda, Porto, Portugal.;CUF Porto Hosp & Inst, Allergy Unit, Porto, Portugal..
Show others and affiliations
2025 (English)In: PULMONOLOGY, ISSN 2531-0437, Vol. 31, no 1, article id 2466920Article in journal (Refereed) Published
Abstract [en]
Introduction: In 2010, 6.8% of the Portuguese adults had asthma. Contemporary studies employing more accurate methods are needed. We aimed to assess asthma prevalence in Portugal and to identify associated-factors.
Methods: A population-based nationwide study was conducted from May 2021 to March 2024. A multistage random sampling approach was applied to select adults from primary care. Stage 1 involved a telephone screening interview to collect socio-demographic and clinical data. Patients with an Adult Asthma Score (A2 Score) >= 1 were eligible for Stage 2, and 5% of those with an A2 Score = 0 were also invited to participate in Stage 2, which consisted of a diagnostic visit with a physical examination and diagnostic tests. We computed weighted asthma prevalence estimates and multivariable logistic regression models were used.
Results: A total of 7,556 participants completed Stage 1 and 1,857 Stage 2. The prevalence of asthma was 7.1% (95%CI = 6.3-8.0%), with slight differences by sex, age, and region. Education, family history of asthma, inhaler prescription, nasal/ocular symptoms, food allergies, and previous allergy skin tests were associated with an increased risk of asthma (R2 = 33%). Asthma diagnosis could also be predicted by the A2 score, either on its own (R2 = 43%) or in combination with family history and previous allergy skin tests (R2 = 45%).
Discussion: Asthma affects 7.1% of Portuguese adults. Family history of asthma, nasal/ocular symptoms, and comorbid food allergy are associated with increased risk of asthma.
Place, publisher, year, edition, pages
Taylor & Francis, 2025. Vol. 31, no 1, article id 2466920
Keywords [en]
Asthma, epidemiology, prevalence
National Category
Respiratory Medicine and Allergy Public Health, Global Health and Social Medicine
Identifiers
URN: urn:nbn:se:uu:diva-553534DOI: 10.1080/25310429.2025.2466920ISI: 001446022500001PubMedID: 40094487OAI: oai:DiVA.org:uu-553534DiVA, id: diva2:1948340
Funder
AstraZeneca2025-03-282025-03-282025-03-28Bibliographically approved